Focus: Bispecific antibody and iPSC-derived, TALEN gene-edited NK-cell platforms
Cytovia Therapeutics is a life sciences company focused on Bispecific antibody and iPSC-derived, TALEN gene-edited NK-cell platforms.
No open positions listed yet.